Observational studyNeurology2025
Cerebral Sinovenous Thrombosis in Children With Acute Bacterial Intracranial Infection.
Observational study in Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
BACKGROUND AND
objectivesThe epidemiology and optimal treatment strategy of cerebral sinovenous thrombosis (CSVT) in children with acute bacterial intracranial infection is largely unknown. We aimed to define the prevalence of CSVT among children with acute bacterial intracranial infection at a tertiary care pediatric hospital, to identify risk factors associated with the development of CSVT in this population, and to describe the use of anticoagulation in these children at our institution.
methodsThis was a retrospective observational cohort study of children aged 1-18 years hospitalized at a tertiary care children's hospital for acute bacterial intracranial infection between January 1, 2015, and March 31, 2023. Children with bacterial meningitis/meningoencephalitis, cerebritis, intraparenchymal abscess, subdural empyema, and/or epidural abscess who had at least 1 head imaging study were included. Cases were identified using ICD codes; medical charts were manually screened to confirm diagnoses. A multivariable logistic regression model was built to identify independent risk factors for the primary outcome of CSVT using the least absolute shrinkage and selection operator technique.
resultsOf 108 patients included (median age 10 years, 41% female), 33 (31%) developed CSVT. The prevalence of CSVT did not vary by year, but the absolute number of hospitalizations for acute bacterial intracranial infection rose during the study period, particularly after 2020. Presenting neurologic signs/symptoms did not differ between those who did and did not develop CSVT. Mastoiditis (adjusted odds ratio [aOR] 12.2, 95% CI 3.1-48.5), cerebritis (aOR 4.6, 95% CI 1.5-14.5), extra-axial focal suppurative infection (aOR 10.2, 95% CI 1.7-61.6), and dehydration (aOR 3.9, 95% CI 1.0-15.1) were each independently associated with CSVT. Seventy-three percent of children with CSVT (24/33) received anticoagulation (median duration 91 days) with no major bleeding events. All children with CSVT had at least partial thrombus resolution; 60% (20/33) had complete resolution. DISCUSSION: CSVT is common in children with acute bacterial intracranial infection but difficult to clinically identify. Clinicians should maintain a high index of suspicion for CSVT in this population and consider appropriate screening imaging studies, particularly in children with mastoiditis, cerebritis, extra-axial focal suppurative infection, and/or dehydration. Anticoagulation was well-tolerated in this cohort; further studies should focus on determining its safety, benefit, and ideal duration in infection-related CSVT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.